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Expansion of trinucleotide repeats in coding and non-coding regions of genes is associated with sixteen neurodegenerative
disorders. However, the molecular effects that lead to neurodegeneration have remained elusive. We have explored the role of
transcriptional dysregulation by TATA-box binding protein (TBP) containing an expanded polyglutamine stretch in a mouse
neuronal cell culture based model. We find that mouse neuronal cells expressing a variant of human TBP harboring an
abnormally expanded polyQ tract not only form intranuclear aggregates, but also show transcription dysregulation of the
voltage dependent anion channel, Vdac1, increased cytochrome c release from the mitochondria and upregulation of genes
involved in localized neuronal translation. On the other hand, unfolded protein response seemed to be unaffected. Consistent
with an increased transcriptional effect, we observe an elevated promoter occupancy by TBP in vivo in TATA containing and
TATA-less promoters of differentially expressed genes. Our study suggests a link between transcriptional dysfunction and cell
death in trinucleotide repeat mediated neuronal dysfunction through voltage dependent anion channel, Vdac1, which has
been recently recognized as a critical determinant of cell death.
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INTRODUCTION
Expansion of CAG repeats in coding regions resulting in expanded
polyglutamine stretches in proteins is associated with nine
neurodegenerative disorders. Though the mechanistic basis of
trinuleotide repeat expansion has been studied extensively, the
molecular effects that lead to neurodegeneration have remained
elusive, in spite of common features of these disorders implying
a shared mechanism [reviewed in [1]]. Huntington’s disease, the
most common of the neurodegenerative disorders caused by the
expansion of a CAG repeat in the coding region of the Htt protein
has been studied extensively to establish the mechanism of
neurodegeneration and for developing therapeutic applications
[2]. In many cases, limited knowledge about the normal functions
of the protein has prevented studies into the loss/gain of function
due to Trinucleotide Repeat Expansion in them.
Spinocerebellar Ataxia 17, is caused by the expansion of
a polyglutamine repeat in the poorly conserved, structurally
uncharacterized N- terminal half of the human TATA binding
protein. The length of the polyglutamine stretch ranges from 29 to
42 in normal individuals whereas in patients they maybe as high as
63 [3–5]. The disease is characterized by neurodegeneration in
specific regions of the brain at the morphological level and clinical
symptoms like gait disturbance, tremor and dementia. TBP a general
transcription factor for a majority of eukaryotic promoters, binds to
the core promoter element, TATA box (TAT/AAAT) upstream of
transcription start site and initiates transcription by allowing
assembly of pre-initiation complex [6,7]. The detection of TBP in
intranuclear protein aggregates in brain tissues fromHuntington and
Alzheimer patients [8] and the association of expanded polygluta-
mine stretches in TBP with Huntington like symptoms in
a Caucasian family [9] have led to the proposal that TBP may
play a more general role in a common mechanism for trinucleotide
repeat expansion mediated neurodegeneration [8,10].
Out of a number of mechanisms proposed for neurodegenera-
tion in trinucleotide repeat expansion disorders, transcriptional
dysregulation and inappropriate response to unfolded protein
accumulation have gained attention in recent years. The strongest
evidence for transcriptional dysregulation comes from the
observed interaction between the glutamine rich regions of Sp1
with Huntingtin protein harbouring polyglutamine expansion in
brain tissue from Huntington patients [11]. Riley and Orr have
recently highlighted the importance of transcriptional regulation in
polyglutamine disorders and suggested that studying the role of
TBP in neurons will help understand how mutations in ubiquitous
transcription factors result in disease effects in a restricted set of
neurons [12].
Here, we have explored the role of transcriptional dysregulation
by expanded polyglutamine stretch containing TBP in SCA17
using a mouse neuronal cell culture based model. Mouse neuronal
cells expressing a variant of human TBP harboring 59Q repeats
were seen to accumulate intranuclear aggregates whereas a variant
harbouring a 16Q stretch did not show any signs of aggregation.
Genes involved in localized neuronal translation, cytoplasmic
beta-actin (Actb), eukaryotic elongation factor2 (Eef2) and
eukaryotic elongation factor 1 (Eef1alpha 1); retrograde transport,
p25 subunit of dynactin (Dctn5); survival related gene, Vdac1 and
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ubiquitin related gene, ubiquitin B (Ubb) were induced in cells
with TBP containing expanded polyQ. On the other hand,
unfolded protein response seemed to be unaffected. Chromatin
Immunoprecipitation studies at a TATA containing and a TATA
less promoter from the differentially expressed genes suggested that
TBP occupancy was elevated in vivo. Overexpression of the
mitochondria and ER associated voltage gated anion channel,
Vdac1, has been shown to affect mitochondrial flux and trigger
apoptosis in non-neuronal cellular models. In our studies, VDAC1
overexpression lead to elevated cytochrome c release and apoptotic
cell death in mouse neuronal cells. We found increased cytochrome c
release and apoptotic cell death from the mitochondria in mouse
neuronal cells expressing a variant of human TBP harboring
abnormally expanded polyQ tract. Our results identify putative link
between transcriptional dysregulation and cell death in trinucleotide
repeat associated neuronal dysfunction.
RESULTS
We used Neuro-2a cells transfected with 16Q and 59Q polyQ
containing TBP alleles in fusion with GFP to study the effect of
polyQ length in TBP on transcription profile from promoters in
their natural genomic context. We substantiated the model by
cytological observation of large intranuclear aggregates only in
cells transfected with TBP variants carrying expanded polyQ (Fig.
S1, Supporting information). A comparison of the microarray
based transcription profile of cells transfected with vector and 59Q
showed distinct differences. Survival related gene, Voltage
dependent anion channel (Vdac1) and ubiquitin related gene,
ubiquitin B (Ubb) and genes involved in localized neuronal
translation, cytoplasmic beta-actin (Actb), eukaryotic elongation
factor2 (Eef2) and eukaryotic elongation factor 1 (Eef1alpha 1);
retrograde transport, p25 subunit of dynactin (Dctn5), were
amongst the genes that showed significant upregulation in 59Q
transfected cells as compared to internally normalized expression
levels in vector transfected controls (Fig. 1). The results from
microarray experiments were confirmed using real-time PCR
analysis (Fig. 2A) and northern blotting (Fig. 3). In comparison
with vector transfected controls, 16Q-TBP transfected cells
showed marginal elevation of the expression levels of all the genes
tested. But the level of induction was however significantly lower
than that in 59Q TBP transfected cells in all cases barring Eef1a1.
The upregulation of genes in 16Q TBP may be a consequence of
higher total levels of functional TBP resulting from expression of the
endogenous as well as the transfected gene. The situation in 59Q
TBP transfected cells is likely to be totally different due to the
apparent aggregation of a significant fraction of the transfected
protein (Fig. S1, Supplemental materials). Any indirect effect arising
from differential transfection or expression of the transfected TBP in
16Q and 59Q constructs was ruled out by real-time PCR analysis
and northern analysis of GFP transcript expressed in fusion with the
transfected TBP alleles (Fig. 2B, Fig. 3A–C).
It has been shown that many gene specific transcription factors
exert their effects by directly or indirectly interacting with TBP
and stabilizing TBP-TATA box interaction at the proximal
promoter region [13,14]. Therefore we studied the effect of polyQ
length on TBP occupancy at promoters of differentially expressed
genes by chromatin immunoprecipitation(ChIP) using TBP specific
N12 antibody. We used anti-TBP antibody rather than the 1C2
antibody against polyQ as 1C2 antibody interacts with polyQ
stretches in other transcription factors also and anti-TBP antibody
recognizes TBP expressed from the endogenous gene as well as
transfected gene. Total TBP localization to promoters seems to be
a better index of promoter occupancy since normal and expanded
polyQ TBP co-exists in the cell and may form heterodimers.
Promoter occupancy of TBP was higher in 59Q TBP transfected
cells compared to N3 and 16QTBP transfected cells at the Vdac1
and Actb promoters (Fig. 4). The Vdac1 gene was predicted to be
under the control of a TATA-less promoter [15]. The predicted Sp1
site in the Vdac1 gene was of special interest since aberrant Sp1
mediated interaction has earlier been implicated in Huntington’s
disease mechanism [11]. TBP localization could not be demonstrat-
ed in spite of repeated attempts at amplifying the region spanning the
predicted Sp1 site (Fig. 4C, lower). On the other hand, TBP
occupancy at the sterol repressor element 1 (SRE1) site, further
upstream was enhanced in the presence of expanded polyQ variants
(Fig. 4C, upper). We examined the downstream cellular effects of the
upregulation of Ubb and Vdac1 to correlate the changes in gene
expression to neurodegeneration.
The cell responds to aggregated protein accumulation in two
ways: initially a corrective mechanism is adopted through the
unfolded protein response/ ER stress pathway, which induces
chaperones and provides an environment for correct folding of the
proteins and finally, ubiquitinylation and destruction of the
malformed proteins are attempted. Ubb was amongst the genes
with increased expression in cells expressing expanded polyQ
containing TBP. We analyzed the Unfolded Protein Response
pathway using xbp1-splicing assay as an indicator [16]. The ratio
of the spliced and unspliced variants of xbp1 showed no alteration
in cells expressing the different polyQ TBP alleles (Fig. 5).
Recently, the voltage dependent anion channel, Vdac1, has been
shown to localize to both the mitochondrial outer membrane and the
cytoplasmic membrane [17]. A change in the expression level of
Vdac1 has recently been shown to be a critical determinant of cell
death in embryonic kidney cells [18]. Vdac1 plays an important role
in transport of ATP, calcium ions and other metabolites across the
mitochondrial membrane [19]. Calcium induced permeability
transition and cytochrome c release from the mitochondria is
enhanced in cellular models expressing the mutant huntingtin
protein [20]. Further, Ruan et al., observed that mutant huntingtin
was unable to release cytochrome c in the cytosol and striatal cells
undergo non-apoptotic death [21]. We first confirmed that the
Figure 1. Up-regulation of Dctn5, Vdac1, Ubb, Actb, Eef2 and Eef1a1
in 59QTBP-GFP transfected Neuro-2a cells compared to vector
transfected controls observed by cDNA-microarray analysis. X-axis
depicts transcript name. Z-ratio of each transcript was plotted on Y axis.
Error bar represents mean6SEM of at least two independent microarray
experiments.
doi:10.1371/journal.pone.0001170.g001
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transcriptional upregulation of Vdac1 was associated with a similar
increase in the expression level of the protein. As shown in Fig 6,
a specific antibody against VDAC1 was used to monitor the level of
VDAC1 protein in cells transfected with a vector control, 16Q TBP
or 59Q TBP. VDAC1 protein levels were induced by 30 percent in
59Q TBP containing cells. Further, we studied cytochrome c release
from the mitochondria following increase in VDAC1 expression.
The scheme for subcellular fractionation is presented in Fig 7A.
Cytochrome c release in the cytosolic fraction was monitored by
ELISA. The cells expressing 59Q TBP showed a gradual increase in
cytochrome c release resulting in substantially higher Cyt c levels at
time points beyond 36 hours compared to cells which express the
vector alone (Fig. 7B), in agreement with increased expression of
VDAC1. We further monitored apoptotic cell death using flow
cytometry of AnnexinV positive cells. Neuro-2a cells harbouring
polyglutamine expanded TBP showed 48% apoptotic cells while
control cells showed less than 30% apoptotic cells (Fig. 7C).
Previous studies have shown that overexpression of VDAC1 can
lead to apoptosis in non-neuronal cells. We confirmed a similar
effect of VDAC1 in neuronal cells by cloning and overexpressing
mouse VDAC1 (Fig. 8A–E). Cytochrome c release was three fold
higher in VDAC1 overexpressing cells (Fig. 8F). Consistent with
cytochrome c release, flow cytometric analysis of AnnexinV-
Phycoerythrin (AnnexinV-PE) positive cells revealed that VDAC1
overexpression induced apoptosis (Fig. 8G).
DISCUSSION
In this study we show that alleles of TBP harbouring abnormally
expanded polyQ tracts not only form intranuclear aggregates in
cultured mouse neuronal cells, but also result in overexpression of
the voltage dependent anion channel, Vdac1 at both the RNA and
protein level. VDAC can associate with small ions, control the
passage of key adenine nucleotides, interact with other proteins
like cellular kinases and regulate mitochondrial permeability
[17,19]. VDAC localizes to the outer mitochondrial membrane
and associates with the Adenine nucleotide translocator in the
inner mitochondrial membrane to form the permeability transition
pore through which cytochrome c is released in apoptotic cells.
Pro-apoptotic members of Bcl2 family of proteins like Bax and Bak
are seen to promote Cytc release by binding to and modulating
Figure 2. Real time PCR analysis of gene expression. (A) Differential gene expression of Ubb, Vdac1, Dctn5, Eef2, Eef1a1 and Actb in Neuro-2a cell
line trasfected with human TBP (hTBP) containing different lengths of polyglutamine. Mouse 18s rRNA was used as an endogenous reference. N3 was
used as a calibrator for determining relative expression. (B) Expression levels of reporter (Gfp) in transfected Neuro-2a cells determined by Real time
PCR: similar levels of expression of TBPGFP in 16Q and 59Q transfected cells. N3: tranfected construct contains GFP; 16Q, 59Q: transfected construct
contains GFP tagged hTBP with CAG repeat length 16 and 59 respectively. Data shown are the mean6SEM of two to four independent experiments.
(*, p,0.05, Student’s t-test)
doi:10.1371/journal.pone.0001170.g002
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Vdac action [22]. We independently confirmed that Vdac1
overexpression in mouse neuronal cells results in higher cyto-
chrome c release and apoptosis, as has been reported for non-
neuronal cells previously [23]. In our studies the cells expressing
16Q TBP showed higher constant levels of cytosolic Cyt c
compared to cells which express the vector alone. 59Q TBP cells,
however, showed a significant difference in the cytochrome c
release pattern. At early time points, cytosolic Cyt c levels are
comparable to controls but with time they steadily rise and
saturate at levels 30% higher than in 16Q TBP cells by 70 hours.
Concurrently, 59Q TBP expressing cells showed a 20% increase in
number of apoptotic cells.
Besides, SCA17, caused by the expansion of polyQ tract in the
TATA binding protein itself, normal TBP is also found in intra
nuclear protein aggregates formed in other neurodegenerative
diseases, notably, huntington’s disease [8]. Degeneration of cells in
specific regions of the brain is a well known feature of polyQ
mediated neurodegenerative disorders. Vdac1 overexpression,
independently implicated in triggering cell death was one of the
effects of polyglutamine expansion in TBP, identified in our study.
Our results suggest a previously unknown mechanistic basis linking
transcriptional dysregulation to cell death in neurodegeneration
through TBP mediated alteration of Vdac1 expression.
The promoter of the Vdac1 is predicted to be devoid of a TATA
box [15]. TATA less promoters depend on TBP participation in
the pre-initiation complex by localizing it to the promoter through
other DNA binding proteins. Even at TATA box containing
promoters, TBP binds inefficiently in the presence of chromatin
and requires gene specific trans-activators [13]. We find that TBP
occupancy at the promoter of upregulated genes was elevated
irrespective of the presence of the TATA box. Expansion of polyQ
and formation of TBP containing protein aggregates suggest that
TBP can cause enhanced expression of a downstream gene by
titrating away a gene specific repressor. Alternatively, polyQ
containing TBP can form heterodimers in solution with the
endogenous functional TBP and alter its availability at various
promoters. The structural or functional role of polyQ stretch
within TBP has not been studied. The yeast homolog of TBP does
not have the N-terminal part harboring the polyQ stretch while
a gradual increase in the length of the polyQ stretch during
evolution is observed. The conserved C-terminal domain of TBP is
sufficient for binding to the TATA box and can be co-crystalized
Figure 3. Differential expression of Vdac1 gene, Dctn5 and Ubb in Neuro-2a cells transfected with N3, 16QTBPGFP and 59Q TBPGFP. (A & C)
Northern blot using Vdac1 (A), Dctn5 and Ubb as a probe (C), Gfp probe was used to show expression levels of Gfp and TbpGfp in transfected cells (A,
C), 18s rRNA was used as a loading control (lower panels in A & C); (B, D & E) The intensity of Vdac1 (B), Dctn5 (D) and Ubb (E) band were quantified
and each band intensity was normalised to the band of 18s rRNA. N3 band intensity was used for determining relative expression. N3: tranfected
construct contains GFP; 16Q, 59Q: transfected construct contains GFP tagged hTBP with CAG repeat length 16 and 59 respectively.
doi:10.1371/journal.pone.0001170.g003
Q Expanded TBP Induces VDAC1
PLoS ONE | www.plosone.org 4 November 2007 | Issue 11 | e1170
with it [24]. Using an artificially tethered TBP with promoter-
reporter fusions and at the genome-wide level it has been shown
that many gene specific transcription factors exert their effects by
directly or indirectly interacting with TBP and stabilizing TBP-
TATA box interaction at the proximal promoter region [13,14].
The interaction of expanded polyQ containing TBP with other
factors in the eukaryotic transcription machinery will provide
a more detailed picture of the transcriptional dysregulation.
VDAC action is known to be modulated by pharmacological
agents. Besides synthetic and naturally occurring polyanions like
spermine which increase the voltage dependence of VDAC
channel, ruthenium red can reduce the voltage dependence of
VDAC channel [23]. The potent anti-depressant, Prozac (Fluox-
etine) has earlier been shown to prevent apoptosis and enhance
cell proliferation in the dentate gyrus. Fluoxetine has been shown
to interact with the VDAC channel and modify its voltage
dependence and conductance and in certain cell types can provide
protection from apoptosis [25]. TBP, being a general transcription
factor is likely to have diverse, direct and indirect effects on gene
expression and consequently in cellular function. These effects are
unlikely to be mediated solely through Vdac1. Further investiga-
tions using chemical inhibitors or gene knock down strategies to
negate the elevated Vdac1 transcript level can delineate the
contribution of Vdac1 to the phenotypic effects of polyglutamine
expansion in TATA binding protein.
MATERIALS AND METHODS
Generation of GFP fusion clones
The original human TBP construct containing the human TBP
cloned in NdeI-BamHI site of pET3b vector (Novagen) has been
previously described [26]. The glutamine repeat containing region
of TBP was amplified using following primers:
59-AAGAAGGACATATGGATCAGAACAACAGCC-39
Figure 4. Chromatin immunoprecipitation (ChIP) analysis revealed promoter localization of TBP in transfected Neuro-2a cells. Promoter occupancy of
TBP was higher in 59Q TBPGFP transfected cells as compared to vector (N3) and 16Q TBPGFP transfected cells. (A & B) schematic representation of
regulatory sites in Vdac1 promoter [predicted (16)] (A) and Actb promoter (B); SRE1: Sterol repressor element 1, Sp1: specificity protein 1. Cells transfected
with 16QTBPGFP and 59Q TBPGFP were treated with 1% formaldehyde and chromatin prepared as described earlier [15]. Anti TBP antibody (N-12, Santa
cruz) was used for immuno-precipitation. PCR was performed from immunoprecipitates, total input chromatin (Input). Samples treated without antibody
(No Ab) did not show any product after PCR. PCR product for SRE1 (upper), Sp1 (lower) (C) and Actb promoter (D) were resolved on agarose gel. (E & F)
intensity of band for SRE1 (E) and Actb promoter (F) were quantified and normalized to input band. Data represented relative to the N3 transfected
control. Data shown are mean6SEM of three independent experiments performed. (*, p,0.01, Student’s t-test).
doi:10.1371/journal.pone.0001170.g004
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59-TGCCACTGCCAGCTGTTGCTGCTG-39 which respec-
tively introduced NdeI and PvuII restriction endonuclease site in
the PCR product I. The flanking region 39 to the glutamine repeat
of the TBP was amplified using following primers:
59-CAGCAGCAGCAGCAACAGGCAGTGGCA-39
59-GCTAGTTATTGCTCAGCGGTGGCAGCAGC-39 re-
sulting in PCR product II.
The NdeI and PvuII digested PCR I product, was gel purified.
PCR product II was end filled by using Vent polymerase, digested
with BamHI and gel-purified. These processed PCR products i.e.,
I and II were cloned into BamHI-NdeI digested pET-15b vector
in a three-fragment ligation. However, during the process of
cloning, clones containing 16 and 59 glutamine repeats were
obtained. The clones were sequenced to confirm the presence of
continuous glutamine repeats. The clones were designated as p-
15b16QTBP, and p-15b59QTBP.
Further, human TBP gene was amplified from the p-
15b16QTBP and p-15b59QTBP for re-cloning into pEGFPN3
vector (Clontech). The following primers introduced XhoI and
BamHI site, respectively, in the PCR product:
59-GGAGATCTCGAGATGGATCAGAACAAC-39and
59-GCAGCCGGATCCCGTCGTCTTCCT-39
Underlined sequences in the primers mentioned above
represent the sites for restriction endonucleases. Proof reading
KOD polymerase (Toyobo, Osaka, Japan) was used in the PCR
reaction and the resultant PCR product was digested with BamHI
and XhoI. The gel purified PCR product was cloned in BamHI-
XhoI site of pEGFP-N3 (Clontech) vector, in frame with green
fluorescent protein (GFP). The pEGFP-N3 vector and constructs
were designated as N3, 16Q, and 59Q respectively in this paper.
Cloning of mVdac1
The coding sequence of murine Vdac1 (mVdac1) (gene bank id
NM_011694.3) was amplified from cDNA synthesized from N2a
cells. The following primers introduced BglII and KpnI site,
respectively, in the PCR product (restriction sequence underlined):
Figure 5. Poly Q expanded TBP transfected cells do not show ER
stress. ER stress was detected by reverse transcription (RT) reaction
followed by PCR amplification of spliced (S) and unspliced Xbp1 (U).
PCR products were resolved in 5% polyacrylamide gel, stained with
vista green. (A) Unspliced and spliced Xbp1 PCR products detected in
vector (N3), 16QTBPGFP and 59QTBPGFP transfected Neuro-2a cells (B)
Vista green stained bands were quantified and ratio (spliced/unspliced)
was calculated. Higher ratio in DTT treated positive control indicates ER
stress. 59QTBPGFP and 16QTBPGFP transfected cells were showing
similar ratio as observed in vector (N3) transfected control. Data
represent mean6SEM of two independent experiments.
doi:10.1371/journal.pone.0001170.g005
Figure 6. Expression of VDAC1 protein in Neuro-2a cells transfected with vector (N3), 16QTBPGFP and 59QTBPGFP. (A) Western blotting with
VDAC1 specific antibody (N-18, Santa cruz) [upper panel], TBP specific antibody (N-12, Santa cruz) [middle panel]. Equal sample loading was verified
by staining the blot with Ponceau S. DNA was isolated from transfected cells (see materials & methods) and equivalent amount of plasmid
transfection was checked by PCR amplification using GFP specific primers (Table 1) (B) Immunoreactive band intensity was quantified and plotted.
Data presented relative to the vector (N3) transfected control. Data shown are mean6SEM of three independent experiments performed. (*, p,0.05,
Student’s t-test)
doi:10.1371/journal.pone.0001170.g006
Q Expanded TBP Induces VDAC1
PLoS ONE | www.plosone.org 6 November 2007 | Issue 11 | e1170
59-AAAAGATCTATGGCCGTGCCTCCC-39and
59AAAGGTACCTGCTTGAAATTCCAGTCC 39
The gel purified PCR product was cloned in BglII-KpnI site of
pEGFP-N3 (Clontech) vector, in frame with green fluorescent
protein (GFP) and confirmed by sequencing.
Expression of mVdac1GFP in transfected N2a cells was
confirmed by reverse transcription followed by PCR (RT-PCR).
The following primers were used for amplification:
59-AATGACGGGACAGAGTTTGG-39 (Specific for Vdac1)
59-GGTGTTCTGCTGGTAGTGGT-39 (Specific for GFP)
Expected product size was confirmed by resolving the PCR
product on a 1% agarose gel.
Cell culture and transfection
Murine neuroblastoma cells (ATCC number CCL-131; Neuro-2a or
N2a) were maintained in Minimum essential medium (MEM)
(GIBCO-BRL) supplemented with 10% fetal calf serum [Biological
Industries, Israel], 2 mM L-glutamine [Sigma], 1mM sodium
pyruvate [Sigma] and antibiotic-antimycotic solution (1006 stock)
[Sigma] at 37uC humidified incubator with 5% CO2. Approximately
36105 cells were seeded in each well of 6 well plate (Axygen) 24 h
prior to transient transfection when 50–80% confluency was reached.
Cells were washed once with Opti-MEM (GIBCO-BRL) and
maintained in 1 ml Opti-MEM. 1 mg of transfection quality DNA
(Endo free plasmidmaxi kit; Qiagen) and 3 ml of fugene 6 transfection
reagent (Roche) were used for preparation of transfection complex.
Transfection of N3, 16Q and 59Q was performed following the
protocol from the manufacturer. After 60 h of incubation cells were
observed in an inverted epifluorescence microscope (TE200-U,
NIKON) under 106objective. Transfection has also been performed
by using Amaxa neucleofection technology. Transfection efficiency
was found to be about 45 to 50% and used for normalization.
Confocal analysis
Described in detail in Text S1.
RNA isolation and purification
After 60 H of transfection total RNAwas isolated from the cells using
TRIzol reagent (GIBCO-BRL) according to the manufacturer’s
instruction. The RNA pellets were washed with 70% ethanol,
centrifuged and dried. Pellets were re-suspended into 30 ml of DEPC
treated water followed by the addition of 106 reaction buffer and
2 U of RNAse free DNase I (Fermentas) in a total volume of 45 ml.
Samples were incubated at 37uC for 30 minutes. Then the RNAwas
cleaned using RNeasy Mini Kit (Qiagen) following the protocol by
the manufacturer. RNA concentration and purity was determined
by measuring optical density at 260 nm and 280 nm using
a spectrophotometer (Eppendorf) and running the RNA samples
on a 1.5% agarose formaldehyde gel.
Reverse transcription (RT) and real time polymerase
chain reaction (PCR)
cDNA was generated from the total RNA samples by using
random hexamer (New England biolabs Inc, NEB) and M-MuLV
reverse transcriptase (NEB) at 42uC for 1 h. Real time PCR was
performed using SYBR green master mix (Applied Biosystems,
ABI) in ABI 7500 real time PCR instrument. The forward and
reverse primers are found in Table 1. The real time PCR program
consisted of activation of uracil-N-glycosylase (UNG) at 50uC for
2 min., then 95uC for 10 min to inactivate UNG and activate
ampli Taq Gold DNA polymerase, followed by 40 cycles of
denaturation at 95uC for 15 sec, annealing at 55uC for 30 sec and
extension at 60uC for 1 min. The products were analyzed on 5%
polyacrylamide gel to confirm the appropriate product size.
Data analysis
Relative quantitation of gene expression was carried out using the
mathematical expression described recently [27]. PCR efficiency
of target gene and endogenous control gene has been determined
from the slope of the respective standard curve.
Figure 7. Quantitative analysis of cytochrome c release into the cytosol of transfected Neuro-2a cells. (A) Scheme for isolation of cytosol from
cultured cells; (B) Time dependent release of cytochrome c in the cytosol was measured by using a solid phase ELISA assay. Data represents
mean6SEM (n= 2). (C) Apoptosis in 16Q TBPGFP and 59Q TBPGFP transfected cells were analyzed by counting annexinV-PE positive cells in a flow
cytometer. Data represents mean6SEM of four independent experiments performed. (*, p,0.01, Student’s t-test).
doi:10.1371/journal.pone.0001170.g007
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Microarray studies and data analysis
Total RNA was isolated from N3 and 59Q transfected N2a cells as
mentioned above. Total RNA was labeled by Micromax NEN TSA
labeling system (Perkin-Elmer Life Sciences, USA) according to
manufacturer instruction. Labeled total RNA was hybridized onto
mouse cDNA array (Microarray centre, University Health Network,
Ontario, Canada). Six different replicates were performed from the
cultured N2a cells in different batches. The slides were scanned using
an Axon scanner and data were acquired and analysed using
Genepixpro. Data from 59Q transfected (treated) andN3 transfected
(control) samples were normalized using Z score transformation
method described by Cheadle et al., [28]. Z ratio value 61.96 was
considered significant (p,0.05) [28]. Microarray data has been
submitted to GEO (Accession no. GSE5807).
Northern analysis
Total RNA was transferred to the nylon membrane after
separation on a 1.5% agarose formaldehyde gel. Subsequently,
radioactively labeled probe prepared from purified PCR products
of Vdac1, Dctn5, Ubb and Gfp using NEBlotTM kit (NEB)
according to manufacturer instruction. Hybridized probe signal
was detected by phosphorimager (Fujifilm FLA 2000IR) and
intensity was quantified using MultiGauge software
Chromatin immunoprecipitation (ChIP)
Chomatin immunoprecipitation reaction was performed using
standard protocol [29]. 2 mg anti TBP antibody (N-12:sc-204;
Santa cruz Biotechnology Inc.) was used for immunoprecipitation.
Precipitated DNA samples were analyzed by PCR (35–38 cycles).
The following forward and reverse primers were used for each
gene promoter respectively:
Vdac1 SRE1:
59-GGGAGAGTTTAATTTGCAACTGACT-39
59-CTGGAAGCATTTGGGAAGAG-39
Vdac1 Sp1:
59-GAGACTGGTCTGGGCGCTGTC-39
59-TGGGAGCGCAGCGAACGGGCC-39
Actb:
59-CCATCGCCAAAACTCTTCAT-39
59-AAGGAGCTGCAAAGAAGCTG-39
Figure 8. Over-expression of murine Vdac1 (mVdac1) in Neuro-2a cells induces apoptosis. (A–D) Neuro-2a cells transfected with pEGFPN3 vector alone
(N3) (A & C) andmVdac1GFP (B & D) [A & B, Fluorescent field; C & D, Bright field view under 106objective in an epifluorescencemicroscope (Nikon)]. (Scale
bar,100 um). (E) Expression of mVdac1Gfp in Neuro-2a cells was confirmed by Reverse transcription followed by PCR (RT-PCR) amplification from cDNA
using a Vdac1 specific forward primer and GFP specific reverse primer (Upper panel). Expression of GFP was checked in N3 and mVdac1GFP transfected
cells by RT-PCR using GFP specific forward and reverse primers. RT+: with reverse transcriptase, RT-: without reverse transcriptase. (F) Release of
cytochrome c into cytosol in mVdac1 transfected cells was determined by using a solid phase ELISA method 65H after transfection. Data is presented
relative to vector transfected control (N3). Data represents mean6SEM of two independent experiments each in replicate. (*, p,0.01, Student’s t-test) (G)
Flow cytometric analysis of apoptosis in mVdac1GFP and N3 transfected cells (65H after transfection) was determined by counting annexinV-PE positive
cells. Data represents mean6SEM of two independent experiments, each in replicate. (*, p,0.05, Student’s t-test).
doi:10.1371/journal.pone.0001170.g008
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PCR products were resolved on a 2% agarose gel. Ethidium
bromide stained bands were quantified using Quantity one
software (BioRad). Band intensity was normalized to the input
band.
PCR-based assay for Xbp1 splicing
cDNA synthesized from total RNA isolated from transfected cells
was used as template for PCR. Primers and PCR conditions were
used as described by Marciniak et al. [30]. 480 bp product obtained
from unspliced Xbp1 while spliced Xbp1 gave 454 bp product. PCR
products were separated on 5% polyacrylamide gel and stained with
Vista green (Amersham Biosciences, UK). Fluoroimage was
captured by gel doc system (BioRad Laboratories, USA) and
intensity was quantified using quantity one v 4.1.1 software.
Western analysis
Neuro-2a cells were transfected with vector alone (N3),
16QTBPGFP and 59QTBPGFP using either fugene6 or Amaxa
nucleaofection device. Transfected cells grown on 6-well plate were
scrapped after 60–65 h of incubation. Cells were lysed using 16SDS
sample buffer (50 mM Tris-Cl, pH 6.8, 100 mM 2-mercaptoetha-
nol, 2% (w/v) SDS, 10% glycerol) and incubated at 55uC for 1 h,
then boiled for 5 min. Total protein was estimated using BCA
protein estimation kit (Sigma). Bromo-phenol blue was added to
each sample and equal amount of protein was separated on 12%
SDS-polyacrylamide gel. The separated protein was transferred to
a nitrocellulose membrane and stained with Ponceau S to check
equal loading. Membrane was blocked in a solution of 137 mM
NaCl, 3 mM KCl, 25 mM Tris-HCl, 0.1% Tween 20, pH 7.4
containing 5% (w/v) skimmed milk for overnight at 4uC. VDAC1
specific polyclonal antibody (N-18: sc-8828) (1:500 dilution) was
added and incubated for 2 h at room temperature, washed and then
incubated with alkaline phosphatase (AP) conjugated secondary
antibody (1:3000). For TBP specific western TBP specific polyclonal
antibody (N-12:sc-204) (1:500 dilution) was used. Immunoreactive
bands were detected using BCIP/NBT solution. Western blot was
scanned and band intensity was quantified by using Quantity one
software (BioRad). Transfected N2a cells were lysed by using a lysis
buffer (50 mMTris-Cl pH 8.1, 10 mMEDTA, 1% SDS), boiled for
10 minutes for complete lysis, and then spun at 5000 rpm to remove
debris. DNA has been precipitated from the collected supernatant by
using 5 M Nacl to a final concentration 0.3 M and kept for
overnight at 220uC. DNA was pelleted down, washed with 70%
ethanol and dissolved in TE. PCR amplification from that template
has been performed by using GFP specific primers (Table 1); run on
a 2% EtBr stained agarose gel to resolve the product.
Measurement of cytochrome c release
Neuro-2a cells were transfected using Amaxa nucleaofection device
following manufacturer protocol. Transfected cells were grown on 6
well plates in Opti-MEM (GIBCO-BRL). Cells were scraped after
24 hr, 36 hr, 48 hr and 70 hr of incubation, washed in PBS, washed
in 16 extraction buffer A (10 mM HEPES, pH 7.5, 200 mM
manitol, 70 mM sucrose and 1 mM EGTA)[sigma] and re-
suspended in the same buffer containing 2 mg ml21 bovine serum
albumin (Sigma). After 1 h incubation on ice, cells were lysed by a B-
type Dounce homogenizer with 30–35 strokes. Homogenates were
centrifuged at 4uC in the subsequent steps to remove nuclei, debris
and mitochondria (Fig. 6A). Supernatant was re-centrifuged at
15,0006g at 4uC to get cytosolic fraction. To rule out mitochondrial
contamination in the cytosolic fraction a colorimetric assay was
performed using cytochrome c oxidase assay kit (Sigma) following
manufacturer protocol. Protein estimation in the cytosolic fraction
was performed by using BCA protein estimation kit (Sigma). Equal
amount of protein from cytosolic fraction was used from N3, 16Q
and 59Q transfected samples and cytochrome c concentration was
quantitatively examined by a solid phase ELISA kit (Quantikine H
Rat/Mouse, R & D systems, Minneapolis, MN, USA) according to
the manufacturer’s instructions.
Similar method was followed for Cyt c release assay in case of
mVdac1GFP transfected cells. Assay was performed 65 H after
transfection.
Flow cytometry analysis
Untransfected and transfected N2a cells grown on 6 well plate
were harvested by trypsinization/scrapping. Untransfected cells
were used as a negative control. Cells were stained with Annexin
V-PE and 7-AAD by using NexinTM kit (Guava technologies)
following manufacturer’s protocol. Data acquisition and analysis
were performed by using GuavaEasyCyte flow cytometer and
Guava Nexin cytosoft software (v3.6.1). Transfection efficiency has
been calculated by counting GFP positive cells in the above
mentioned flow cytometer using Guava Express plus software
(v3.6.1). For data analysis total annexin V-PE positive cells were
normalized to transfection efficiency.
SUPPORTING INFORMATION
Figure S1 Confocal analysis of expressed TBP-GFP fusion
protein (green) in the nucleus of transfected Neuro-2a cell line.
Nuclei were stained with Propidium Iodide (red fluorescence).
16QTBP-GFP transfected Neuro-2a cells showed diffused local-
ization to the nucleus (A); multiple large intranuclear aggregates
were observed in cells expressing 59QTBP-GFP fusion proteins
(B). Aggregates are indicated by arrow.
Found at: doi:10.1371/journal.pone.0001170.s001 (5.15 MB TIF)
Table 1. Mouse specific primer sequences and amplicon sizes
used in real time RT-PCR.
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Gene Sequence (59-39) Amplicon size (bp)
Dctn5 F: CGAGGAAGACTGTGTGGTCA 192
R: AGCTCCCCTGAGAAGAGTCC
Actb F: CTAAGGCCAACCGTGAAAAG 126
R: CCATCACAATGCCTGTGGTA
Vdac1 F: AATGACGGGACAGAGTTTGG 231
R: AATGACGGGACAGAGTTTGG
Eef1a1 F: CTTCTCTGACTACCCTCCAC 60
R: CCACAGCTTTGATGACACCC
Eef2 F: TGAGCAAGTGGTGGGTGG 134
R: TGTTGGATCGCAGATCAGCGG
Ubb F: TCTTTCTGTGAGGGTGTTTCG 131
R: GTCACTGGGCTCCACCTCTA
18s rRNA F: CTTTCGAGGCCCTGTAATTG 63
R: CCTCCAATGGATCCTCGTTA
GFP F: CTACAACAGCCACAACGTC 127
R: GGTGTTCTGCTGGTAGTGGT
The table lists the sequences (59 to 39) of the forward and reverse primers used
in real time PCR reaction to amplify various gene transcripts. The size of the
amplicon is given as base pairs (bp). The designation ‘‘F’’ indicates forward and
‘‘R’’ indicates reverse.
doi:10.1371/journal.pone.0001170.t001..
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Text S1
Found at: doi:10.1371/journal.pone.0001170.s002 (0.02 MB
DOC)
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